Introduction
Most tumour types feature hypoxic (low oxygen) regions, and in some neoplastic pathology hypoxia may be present in up to 60% of patients [1] . Generally, tumours with high hypoxic volumes have a poor prognosis because they are associated with an aggressive phenotype and increased risk of metastasis [2] .groups, which should represent a more efficient access to [ 3 H]-FAZA 3.
Results and discussion

Synthesis of FAZA 1
Our synthesis of FAZA (1) is based on the coupling of 2-nitro-1-(triethylsilyl)imidazole 4 with the protected arabinose derivative 5 (Scheme 1), according to the strategy published by Schweifer and Hammerschmidt [10] . The key intermediate 6 was then converted into FAZA (1) following the pathway proposed by Kumar and coworkers [7] .
Both starting substrates 4 (Scheme 2) and 5 (Scheme 3) had to be prepared. Hexaethyldisilazane 9 (Scheme 2, Eq. 1) was prepared from (triethylsilyl)amine 7 and chlorotriethylsilane 8 in the presence of a catalytic amount of triethylsilyl triflate in dry toluene. A refluxing mixture of 2-nitroimidazole (10) and hexaethyldisilazane 9 in pyridine afforded quantitatively the desired substrate 4 (Scheme 2, Eq. 2) [10] .
The synthesis of FAZA (1) (Scheme 3) started from D-arabinose (11) which was fully protected obtaining a mixture of anomeric acetates 5 (a:b = 60:40) [10] . The coupling reaction between 2-nitro-1-(triethylsilyl)imidazole 4 and the anomers 5 afforded the nitroimidazole D-arabinofuranose derivative 6 that was subjected to selective deprotection of the primary hydroxyl group in order to obtain the compound 12 [10] . The subsequent deoxyfluorination was achieved using diethylaminosulfur trifluoride (DAST) in DCM, which gave the protected fluorinated precursor 13 that was then fully deprotected with ammonia in methanol giving FAZA (1) [7] .
Synthesis of [ 2 H]-FAZA 2
Once the synthesis of FAZA 1 was optimized, we switched to the synthesis of the deuterated analogue 2, initially following the procedure reported by Kumar and co-workers [7] . The retrosynthetic approach (Scheme 4) involved the oxidation of the alcohol 12 to the corresponding aldehyde 14a, followed by reduction with a deuterating agent to provide the deuterated alcohol 15a. Subsequently, using the same reactions used for the synthesis of FAZA, we planned to obtain our target molecule 2.
However, in our hands the oxidation step from 12 to 14a (Scheme 5) could not be reproduced following the conditions (Pfitzner-Moffatt oxidation) described by Kumar et al. [7] . It is worth noting that the Kumar's protocol involved the treatment of 12 ''dissolved in anhydrous dimethyl sulfoxide'' with DCC followed by cooling on an ice bath, which not surprisingly in our hands resulted in a solid mixture and no reaction. Upon heating until melting of the mixture, we observed the formation of a complex mixture of unidentified products, in which we could not identify the desired aldehyde 14a.
Stimulated by the need of a more effective and reliable procedure, we first modified the conditions of the Pfitzner-Moffatt oxidation as shown in Scheme 6 and Table 1 , entry 1. We obtained the desired aldehyde 14a but also a consistent quantity of the byproduct 14b, arising from elimination of the acetate in position 3 of the arabinose ring. Unfortunately these two aldehydes could be separated neither by flash chromatography nor by HPLC.
At that point we investigated different oxidation conditions with the aim of suppressing the formation of the by-product 14b (Table 1 , entries 2-6). Eventually, the best conditions we were able to identify afforded a more acceptable 30% of the undesired aldehyde 14b (entry 3).
The inseparable mixture of the two aldehydes 14a and 14b (Scheme 7) was then reduced with deuterated sodium cyanoborohydride (NaBD 3 CN) affording the two deuterated alcohols 15a and 15b. An HPLC separation provided 15a that was deoxyfluorinated with DAST and deprotected with NH 3 /MeOH giving [ 2 H]-FAZA 2. The preparation of 3-deoxy-3,4-didehydro-5-aldehydes such as 14b is a known transformation in carbohydrate chemistry, but it generally involves the treatment of 5-formyl-furanoses having an anti-stereochemistry at carbons 2,3 (ribose and arabinose derivatives) with organic bases such as TEA or DABCO [11], and does not usually occur in the absence of any basic treatment.
In order to better understand the mechanism involved in the spontaneous formation of the elimination by-product, we performed an NMR study (Fig. 2) monitoring the Pfitzner-Moffatt oxidation reaction (DMSO-d 6 , EDC, Cl 2 CHCO 2 H in DMSO-d 6 / benzene-d 6 1:1). We recorded a series of NMR spectra starting from 0 8C and progressively increasing the temperature to 25 8C. In order to monitor the formation of the two aldehydes 14a,b we focussed our attention on the corresponding CHO protons, which have diagnostic low field chemical shifts (9.87 ppm for 14a and 9.81 ppm for 14b in DMSO-d 6 ).
At 0 8C, 5 8C, 10 8C, 158 and 20 8C the reaction did not proceed as it can be seen by the absence of any CHO signal in spectra 1-5, Fig. 2 . When the temperature was increased to 25 8C the aldehyde proton of 14a (signal at 9.87 ppm) started to become visible, meaning that just the desired product was forming (spectra 6-12, Fig. 2) . After 3 h the reaction was quenched by addition of deuterated water. The NMR spectrum was recorded immediately afterwards (spectra 13 Fig. 2) , showing the presence of two aldehyde signals (4:6 ratio), the new signal corresponding to the 14b aldehyde proton at 9.81 ppm. This NMR study therefore demonstrates that the elimination by-product 14b is formed exclusively during the reaction quenching.
Based on the evidence above, we investigated the reaction quenching by testing a number of different conditions after performing the oxidation under the optimized conditions of Table 1 , entry 3. Direct evaporation at reduced pressure without any quenching unexpectedly afforded 14b as the sole product. Filtration on silica gel or Celite 1 without quenching afforded a 14a:14b mixture in 1:9 ratio. Addition of NH 4 Cl instead of water afforded 14a:14b in 7:3 ratio, whereas the use of even mildly basic water solutions produced partial hydrolysis of the acetyl groups. Finally, changing the organic solvent used for the extraction from EtOAc to Et 2 O or DCM had no tangible effect.
The synthesis above is affected by a number of drawbacks, therefore we decided to investigate an alternative and more convenient route to [ 2 H]-FAZA 2. To overcome the elimination of the 3-b-acetoxy group, which is a good leaving group, we focussed our attention on the synthesis of the 2,3 O-PMB protected arabinoside. In fact, we reasoned that elimination of a benzyloxy group should be considerably less favoured than that of an acetoxy group, therefore the elimination side-reaction could be suppressed or limited. Unfortunately attempts to install the O-PMB protection on deacetylated 6 (Scheme 3) failed when NaH and PMBCl or pmethoxybenzyl trichloroacetimidate in combination with PPTS, PTSA or BF 3 were used. A different strategy based on a 3-PMB protected acetate donor was therefore investigated (Scheme 8). Starting from the readily available arabino-acetonide 17, prepared in two steps from Darabinose 11 [12] , the fully protected 3-PMB sugar 18 was obtained in good yield using NaH, PMBCl and TBAI in anhydrous DMF. The hydrolytic acetonide deprotection required extensive optimization, because of the instability of the TBDPS and PMB groups in aqueous hydrochloric and concentrate trifluoroacetic acid respectively. Optimal conditions were found using aqueous TFA (50%) in DCM as solvent. The lactol 19, obtained as a 1:1 mixture of anomers, was then diacetylated with acetic anhydride in pyridine, affording the diacetate glycosyl donor 20, again as an inseparable anomeric mixture in quantitative yields. The glycosylation step was accomplished by treating 20 with 1-triethylsilyl-2-nitroimidazole and a catalytic amount of triethylsilyl triflate in anhydrous acetonitrile at À8 8C affording the 2-nitromidazole glycoside 21 in 76% yield as a single a-anomer, thanks to the anchimeric participation of the 2-b-acetate in the stabilization of the intermediate oxocarbenium ion. The compound 21 was then O-TBDPS deprotected with KF and the key alcohol intermediate 22 was therefore obtained.
As in the previous approach to 2 (see Scheme 7), the alcohol 22 was oxidized to the aldehyde 23 using EDC and DMSO (Scheme 9). Gratifyingly, no elimination products were observed in this case. The reduction with NaBD 3 CN gave the deuterated alcohol 24, that was deoxyfluorinated with DAST to 25a in a rather modest 35% yield, which could not be optimized further. The fluoride 25a was then oxidatively deprotected with CAN to the secondary alcohol 26a which was subjected to the final deacetylation to provide the target [ 2 H]-FAZA 2 in satisfactory overall yields. The corresponding non-deuterated compounds 25,26b were also obtained directly from 22, eventually leading to FAZA 1.
Conclusions
We have conducted a detailed study on the synthesis of one of the most important fluorine-containing compounds in the realm of molecular imaging, FAZA (1) . An optimized approach to deuterium-labelled FAZA (2) was developed as a model process which is expected to greatly facilitate the synthesis of tritium-labelled FAZA (3), a potentially very useful molecular probe for the biological investigation of tumour hypoxia, whose use has been hitherto hampered by its extremely limited availability and difficult preparation. Tritium-labelled FAZA had previously been obtained by means of the same reducing agent used here albeit in tritiumlabelled form, i.e. NaB 3 H 3 CN [7] , therefore we envisage that our synthesis will be actually used for the preparation of 
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F NMR spectra were recorded with complete proton decoupling. The following abbreviations are used to describe spin multiplicity: s = singlet, d = doublet, t = triplet, m = multiplet, dd = doublet-doublet, dt = doublet-triplet, ddd = doublet-doublet-doublet, and br = broad signal. All chemical shifts (d) are expressed in parts per million and coupling constant (J) are given in Hertz. LC-MS experiments were performed on an Agilent Technologies 1200 Series HPLC system equipped with a DAD and a 6120 MS detector composed by a ESI ionization source and a Single Quadrupole mass selective detector using a Analytical C18 RP column (Phenomenex Luna, C18, 250 mm Â 4.60 mm, 5 m, 100 Å´). HPLC purifications were performed on the Agilent 1200 system using a semi preparative C18 RP column (Phenomenex Luna, 250 mm Â 10.00 mm, 5 m, 100 Å´). All reactions were carried out in oven-or flame-dried glassware under nitrogen atmosphere, unless stated otherwise. All commercially available reagents were used as received. Reactions were magnetically stirred and monitored by TLC on silica gel (60 F254 pre-coated glass plates, 0.25 mm thickness). Visualization was accomplished by irradiation with a UV lamp and/or staining with a ceric ammonium molybdate or KMnO 4 solution. Flash chromatography was performed on silica gel (60 Å , particle size 0.040-0.062 mm). Yields refer to chromatographically and spectroscopically pure compounds, unless stated otherwise. Abbreviations used: DMSO for dimethylsulfoxide, DCM for dichloromethane, THF for tetrahydrofurane, EtOAc for ethyl acetate, DMF for dimethylformamide, Et 2 O for diethyl ether, Py for pyridine, DMP for Dess-Martin periodinane, TFA for trifluoroacetic acid, TESOTf for triethylsilyl trifluoromethanesulfonate, EDC for N-(3-dimethylaminopropyl)-N-ethylcarbodiimide, DAST for (diethylamino)sulfur trifluoride, CAN for ammonium cerium(IV) nitrate, and TBAI for tetrabuthylammonium iodide. Compounds 5, 6, 7, 9 and 12 were synthesized as previously described [10] . The synthesis of compound 13 and its conversion to 1 were performed as previously described [7] . The alcohol 12 (150 mg, 0.15 mmol) was dissolved in a mixture of DMSO/benzene 1:1 (4. 
(2S,3S,4R,5R)-4-(acetyloxy)-5-[hydroxy(2H 1 )methyl]-2-(2-nitro-1H-imidazol-1-yl)oxolan-3-yl acetate (15a)
The inseparable crude mixture of the two aldehydes 14a and 14b was dissolved in ethanol (1.5 mL), cooled at 0 8C and NaBD 3 CN (9.3 mg, 0.15 mmol) was added. The pH was adjusted to 4.5 adding one or two drops of acetic acid and the mixture was allowed to warm to r.t. and stirred overnight. The solvent was then removed under reduced pressure and the residue was dissolved in EtOAc (22 mL). The organic layer was washed with water (5 mL), brine (5 mL), dried over MgSO 4 
(2S,3S)-5-[hydroxy(2H 1 )methyl]-2-(2-nitro-1H-imidazol-1-yl)-2,3-dihydrofuran-3-yl acetate (15b)
Synthesized from the mixture of two aldehydes 14a and 14b as 15a (see above 
(2S,3S,4S,5S)-4-(acetyloxy)-5-[fluoro(2H 1 )methyl]-2-(2-nitro-1H-imidazol-1-yl)oxolan-3-yl acetate (16)
To an ice cooled solution of 15a (15 mg, 0.05 mmol) in anhydrous DCM (0.2 mL), DAST (6.5 mL, 0.048 mmol) was added drop wise under stirring. After 10 min the reaction was slowly warmed to r.t. and stirred for additional 30 min. The mixture was then cooled to 0 8C and MeOH (0.06 mL) was added to quench the reaction. The solvent was removed under reduced pressure and the crude product was purified by flash chromatography (Hexane/ EtOAc 1:9) to give compound 16 (7.5 mg, 45%) as a pale yellow oil. 
(2S,3S,4S,5S)-2-[fluoro(2H
To neat compound 16 (3. 
{[(3aS,5R,6R,6aS)-6-[(4-methoxyphenyl
To a solution of 17 (synthesized as previously reported [12] , 2.6 g, 6.0 mmol) and p-methoxybenzyl chloride (1.2 mL, 9.0 mmol) in anhydrous DMF (35 mL) cooled at 0 8C, TBAI (222 mg, 0.6 mmol) was added followed by the addition of NaH (60% in mineral oil, 480 mg, 12 mmol) under vigorous stirring. After 10 min the ice bath was removed and the reaction was allowed to warm to r.t. and stirred for additional 6 h. The reaction mixture was then cooled to 0 8C and the excess of NaH was carefully quenched with water. The mixture was acidified (pH = 2) adding 1 M HCl and extracted with EtOAc (3 Â 30 mL); the combined organic phases were washed with brine (10 mL) dried over MgSO 4 , filtered and concentrated under reduced pressure. 
(3S,4S,5R)-5-{[(tert-butyldiphenylsilyl)oxy]methyl}-4-[(4-methoxyphenyl)methoxy]oxolane-2,3-diol (19)
Compound 18 (1.0 g, 1.8 mmol) was dissolved in DCM (50 mL) and the solution was cooled to 0 8C. TFA (50% in water, 20 mL) was added under vigorous stirring and the reaction mixture was allowed to warm to r.t. After 3 h the mixture was quenched by careful addition of small portions of solid NaHCO 3 . Water was added and the mixture was extracted with EtOAc (3 Â 30 mL). The organic layer was washed with brine, dried over MgSO 4 , filtered and the solvent evaporated under reduced pressure. The crude product was purified by flash chromatography (Hexane/EtOAc 1:1) to give a mixture of two anomers (481 mg, 52%) as a colourless oil. 
(3S,4R,5R)-2-(acetyloxy)-5-{[(tertbutyldiphenylsilyl)oxy]methyl}-4-[(4-methoxyphenyl)methoxy]oxolan-3-yl acetate (20)
To a solution of 19 (480 mg, 0.94 mmol) in anhydrous pyridine (3 mL), acetic anhydride (0.50 mL, 5.20 mmol) was added drop wise and the mixture was stirred overnight. The volatile components were evaporated under reduced pressure, EtOAc (20 mL) was added and the mixture was washed with 0.5 M HCl (10 mL), saturated NaHCO 3 and brine. The organic layer was dried over MgSO 4 , filtered and the solvent evaporated under reduced pressure. The mixture of two anomers 20 was obtained (557 mg, 100%) as a pale yellow oil and was used without further purification. Rf 0. 4 2-Nitroimidazole (85 mg, 0.75 mmol) and bis(triethylsilyl)amine (580 mg, 1.50 mmol) were refluxed in anhydrous pyridine (1.5 mL) for 30 min. The volatiles were removed under high vacuum distillation. The remaining solid was dissolved in anhydrous CH 3 CN (3 mL) and a solution of 20 (345 mg, 0.58 mmol) in anhydrous CH 3 CN (2 mL) was added. The mixture was cooled to À20 8C and TESOTf 1 M in DCM (0.6 mL, 0.60 mmol) was added drop wise under stirring. The reaction was warmed to À8 8C and stirred at this temperature for 3 h. A saturated solution of NaHCO 3 (2 mL) was added and the mixture was extracted with EtOAc (3 Â 20 mL). The organic phase was washed with brine (5 mL The alcohol 22 (41 mg, 0.10 mmol) was dissolved in a DMSO/ benzene 1:1 mixture (3 mL) cooled to 0 8C. Pyridinium trifluoroacetate (8.7 mg, 0.05 mmol) and EDC HCl (51.8 mg, 0.27 mmol) were added and the reaction mixture was allowed to warm to r.t. After 2 h the reaction was quenched with water and extracted with EtOAc (3 Â 150 mL). The organic layers were washed with brine (3 Â 5 mL), dried over MgSO 4 , filtered and the solvent was evaporated under reduced pressure. The crude aldehyde 23 (40 mg) was obtained as a pale yellow oil and was used directly without further purification. Rf 0.50 (EtOAc 100%); 1 The crude aldehyde 23 was dissolved in ethanol (1 mL), cooled at 0 8C and NaBD 3 CN (5.6 mg, 0.09 mmol) was added. The pH was adjusted to 4.5 by adding one or two drops of acetic acid and the mixture was allowed to warm to r.t. and stirred overnight. The solvent was then removed under reduced pressure and the residue was dissolved in EtOAc (20 mL). The organic layer was washed with water (5 mL), brine (5 mL), dried over MgSO 4 Compound 25a (5.8 mg, 0.014 mmol) was dissolved in an acetone/water 4:1 mixture (0.5 mL) then a solution of CAN (15.5 mg, 0.028 mmol) in water (0.2 mL) was added drop wise under stirring. After 30 min another portion of CAN (15.5 mg, 0.028 mmol) in water (0.2 mL) was added. After additional 30 min a saturated solution of NaHCO 3 (1 mL) was added and the mixture was extracted with EtOAc (3 Â 10 mL). The organic layers were washed with brine (3 Â 2 mL), dried over MgSO 4 , filtered and the solvent was evaporated under reduced pressure. The crude product was purified by flash chromatography (Hexane/EtOAc 2:8) to give compound 26a (3.8 mg, 93%) as a waxy solid. Rf 0.62 (EtOAc 100%);
